Full name
"CENTRUM SYNTEZY MOLEKUŁ" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
21.10.Z - Manufacture of basic pharmaceutical substances
10.86.Z - Manufacture of homogenised food preparations and dietetic food
20.42.Z - Manufacture of perfumes and toilet preparations
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
52.10.B - Warehousing and storage of other goods
64.92.Z - Other credit granting
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 140,8 | 138,2 | 133,8 | -3,2 |
Gross profit (loss) | -10,4 | -3,3 | -4,4 | -31,7 |
Net profit (loss) | -10,4 | -3,3 | -4,4 | -31,7 |
Liabilities and provisions for liabilities | 5,3 | 6,1 | 6 | -1,6 |
Income tax | 0 | 0 | 0 | 0 |
Equity capital | 135,5 | 132,2 | 127,8 | -3,3 |
Working assets | 140,8 | 138,2 | 133,8 | -3,2 |
Basic operational activity income | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -7,7 | -2,5 | -3,4 | -0,9 |
Equity capital to total assets | 96,2 | 95,6 | 95,6 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane